Wealthcare Advisory Partners’s OncoSec Medical Incorporated ONCS Stock Holding History

Wealthcare Advisory Partners’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7	Closed	-$1K	–	2114
2021 Q1	$1K	Buy	+7	New	+$958	﹤0.01%	2056
2020 Q2	–	Sell	-7	Closed	–	–	1528
2020 Q1	$0	Hold	7	–	–	﹤0.01%	1635
2019 Q4	$0	Hold	7	–	–	﹤0.01%	1477
2019 Q3	$0	Hold	7	–	–	﹤0.01%	1457
2019 Q2	$0	Hold	7	–	–	﹤0.01%	1387
2019 Q1	$1K	Hold	7	–	–	﹤0.01%	1203
2018 Q4	$1K	Hold	7	–	–	﹤0.01%	1189
2018 Q3	$2K	Hold	7	–	–	﹤0.01%	1152
2018 Q2	$2K	Hold	7	–	–	﹤0.01%	1154
2018 Q1	$3K	Hold	7	–	–	﹤0.01%	939
2017 Q4	$2K	Hold	7	–	–	﹤0.01%	952
2017 Q3	$1K	Buy	+7	New	+$1.56K	﹤0.01%	868

Other funds holding ONCS

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Wealthcare Advisory Partners's ONCS Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of OncoSec Medical Incorporated (ONCS) in Q2 2021, closing a stake of 7 shares — an estimated $1K sold.

Wealthcare Advisory Partners first reported a position in ONCS in Q3 2017 and held it in 12 quarters. The position peaked at $3K in Q1 2018. 35 funds tracked by Wall St. Rank hold ONCS as of Q2 2021.

Wealthcare Advisory Partners reported no remaining OncoSec Medical Incorporated position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 7 OncoSec Medical Incorporated shares in Q2 2021, an estimated $1K.
Wealthcare Advisory Partners first reported a position in OncoSec Medical Incorporated in Q3 2017 and held it in 12 quarters.
Wealthcare Advisory Partners's OncoSec Medical Incorporated position peaked at $3K in Q1 2018.
35 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.